SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

NCT05782192 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

458

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: SAL067
DRUG: Alogliptin
DRUG: Placebo

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.